Announced Mon, 10 Nov · 15:04 IST

Incorporation of subsidiary company.

Strategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Shukra Pharmaceuticals has incorporated a new wholly-owned subsidiary called Shukra Robotics Private Limited on November 7, 2025, with the Ministry of Corporate Affairs issuing the certificate of incorporation on November 9, 2025. The listed company will hold 85% of the subsidiary's paid-up share capital, starting with an initial investment of ₹85,000 (8,500 equity shares of ₹10 each). The new subsidiary will operate in hospital activities, healthcare services, and the manufacture of other medical and dental instruments. The move is described as part of the company's strategic objective to expand its presence in the healthcare and wellness sector.

Likely market impact

The initial capital outlay is very small (₹85,000), so there is no immediate financial impact on the listed entity. However, it signals management's intent to diversify into adjacent healthcare verticals such as medical devices and diagnostics, which could be a positive strategic move if executed well.